A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases

AUTOR(ES)

Richon, Victoria M.

FONTE

The National Academy of Sciences

RESUMO

Hybrid polar compounds (HPCs) have been synthesized that induce terminal differentiation and/or apoptosis in various transformed cells. We have previously reported on the development of the second-generation HPCs suberoylanilide hydroxamic acid (SAHA) and m-carboxycinnamic acid bishydroxamide (CBHA) that are 2,000-fold more potent inducers on a molar basis than the prototype HPC hexamethylene bisacetamide (HMBA). Herein we report that CBHA and SAHA inhibit histone deacetylase 1 (HDAC1) and histone deacetylase 3 (HDAC3) activity in vitro. Treatment of cells in culture with SAHA results in a marked hyperacetylation of histone H4, but culture with HMBA does not. Murine erythroleukemia cells developed for resistance to SAHA are cross-resistant to trichostatin A, a known deacetylase inhibitor and differentiation inducer, but are not cross-resistant to HMBA. These studies show that the second-generation HPCs, unlike HMBA, are potent inhibitors of HDAC activity. In this sense, HMBA and the second-generation HPCs appear to induce differentiation by different pathways.

Documentos Relacionados

• Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
• Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process.
• Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
• Regulation of Mammalian Epithelial Differentiation and Intestine Development by Class I Histone Deacetylases
• Association of Class II Histone Deacetylases with Heterochromatin Protein 1: Potential Role for Histone Methylation in Control of Muscle Differentiation